Matthew Hnatow, MD
Adult Reconstructive Orthopaedic Surgery · Corpus Christi, TXNPI 1114311669
Payments from drug & device makers
What this record shows
This record is dominated by education: $16,095 of the $24,212 with a category attached, or 66.5%. Smith+Nephew accounts for 63.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $7,876 and has fallen 91.1% since, to $703 in 2025.
Across 99 payments — averaging $244.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- Stryker$7K
- Medinc Of Texas$1K
- Davol Inc.$125
- Pacira Pharmaceuticals Incorporated$59
- Innovation Technologies Inc$50
- plus $120 from 6 others
What the payments were for
- Travel & lodging$3,26113%
- Food & beverage$4,85620%
- Education$16,09566%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $15,377 |
| Stryker | 83 | $7,386 |
| Medinc Of Texas | 1 | $1,095 |
| Davol Inc. | 1 | $125 |
| Pacira Pharmaceuticals Incorporated | 2 | $59 |
| Innovation Technologies Inc | 1 | $50 |
| Kerecis Limited | 1 | $36 |
| Alafair Biosciences, Inc. | 1 | $26 |
| Next Science LLC | 1 | $17 |
| Vertex | 1 | $16 |
| Medical Device Business Services, Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$5,124
- TRIATHLON$715
- Journey II$586
- BIRMINGHAM HIP$293
- REAL INTELLIGENCE$293
- Legion Revision$293
- TRIDENT$144
- T2$144
- GMRS$140
- ARISTA AH FLEXITIP$125
How this compares
$24,212 in reported general payments places this provider in the 65th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 262 | $3,476 |
| Cefepime Hcl | 23 | $2,653 |
| Vancomycin Hcl | 22 | $2,488 |
| Gabapentin | 159 | $1,127 |
| Tramadol Hcl | 93 | $1,069 |
| Oxycodone Hcl | 127 | $988 |
| Doxycycline Hyclate | 12 | $448 |
| Ondansetron OdtOndansetron | 67 | $391 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $290 |
| Cefadroxil | 28 | $227 |
| Pregabalin | 19 | $167 |
| Ondansetron Hcl | 41 | $159 |
| Meloxicam | 19 | $59 |
| Amoxicillin | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Corpus Christi
- Jason ThompsonCorpus Christi$25K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$3.8M
- John BarringtonPlano$2.2M
- Roger EmersonPlano$691K
- Donald HohmanDallas$537K
- Steven WeedenFort Worth$370K
- Marcus FordFort Worth$296K
- Raul MarquezEdinburg$278K
- Richard ReitmanPlano$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.